Microbot Medical Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies
Microbot Medical Inc. is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed the world’s first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems.
Current Price
$1.85
+0.00%Profile
Valuation (TTM)
Market Cap$124.24M
P/E-8.74
EV—
P/B1.60
Shares Out67.16M
P/Sales1183.26
Revenue$105000.00
EV/EBITDA—
Microbot Medical Inc (MBOT) Stock Analysis
Market Cap$124.24M
Current Price$1.85
P/E Ratio-8.74
Forward P/E—
PEG Ratio0.23
EPS$-0.29
Book Value$1.15
P/B Ratio1.60
MBOT Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 3M
Revenue
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
Net Income
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
MBOT 52-Week Range
$1.62
$4.50
50-Day MA: $2.35200-Day MA: $2.52
Did you know?
Currently near its 52-week low — in the bottom 8% of its range.
Microbot Medical Inc (MBOT) Financial Summary
Microbot Medical Inc (MBOT) is a Healthcare company in the Medical Instruments & Supplies industry, listed on NASDAQ. The stock currently trades at $1.85 with a market capitalization of $124.24M.
Key valuation metrics include a P/E ratio of -8.74, price-to-book ratio of 1.60, and EPS of $-0.29. The company reports a profit margin of -13535.2% and return on equity of -18.3%.
MBOT Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $124.24M |
| P/E Ratio | -8.74 |
| EPS | $-0.29 |
| P/B Ratio | 1.60 |
| P/S Ratio | 1183.26 |
| Profit Margin | -13535.2% |
| Return on Equity | -18.3% |
| Debt/Equity | 0.01 |
MBOT Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $0.00 | $-7.25M |
| FY20 | $0.00 | $-9.17M |
| FY21 | $0.00 | $-11.31M |
| FY22 | $0.00 | $-13.17M |
| FY23 | $0.00 | $-10.74M |
| FY24 | $0.00 | $-11.44M |
| FY25 | $0.00 | $-13.14M |
MBOT Quality Indicators
Microbot Medical Inc maintains a profit margin of -13535.2%. Return on equity stands at -18.3%. The current ratio is 23.33. Debt-to-equity ratio is 0.01.
About Microbot Medical Inc
Microbot Medical Inc. is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed the world’s first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems.
MBOT Free Cash Flow
Microbot Medical Inc generated $-13.11M in trailing twelve-month free cash flow, representing an FCF yield of -10.55%. This low FCF yield may reflect heavy reinvestment or growth spending.
MBOT Shares Outstanding
Microbot Medical Inc has 0.07 billion shares outstanding at a share price of $1.85, giving it a market capitalization of $124.24M.